Study to Investigate Comparative Pharmacokinetics, Safety, Immunogenicity and Tolerability Between AVT80 and Entyvio

NCT06732804 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

385

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Male and Female Subjects

Interventions

BIOLOGICAL: AVT80
BIOLOGICAL: Geographical region 1 Entyvio
BIOLOGICAL: Geographical region 2 Entyvio

Sponsor

Alvotech Swiss AG